Experimental cancer drug trial halted early

NCT ID NCT05861947

First seen Apr 24, 2026 ยท Last updated Apr 24, 2026

Summary

This early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors (lung, stomach, bladder, kidney, colon, or esophageal cancer) that had come back or spread. The main goals were to find a safe dose and understand how the drug moves through the body. The trial was terminated before completion, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • All India Institute of Medical Sciences

    Bhubaneswar, Odisha, 751019, India

  • Kiran Multi Super Specialty Hospital

    Surat, Gujarat, 395004, India

  • Moraya Multispeciality Hospital (Ashwin Medical Foundations)

    Pune, Maharasthra, 411033, India

  • Omega Hospital

    Visakhapatnam, Andhra Pradesh, 530040, India

  • Sankalp Speciality Hospital

    Nashik, Maharashtra, 422009, India

  • Unique Hospital Multispeciality and Research Institute

    Surat, Gujarat, 395002, India

Conditions

Explore the condition pages connected to this study.